Analysis revealed that patients with T-cell exhausted archetype tumors had significantly higher rates of progressive disease ...

The blood cancer multiple myeloma is deadly. This disease is personal for us because one of our best friends and colleagues ...

In CAR T-cell therapy for diffuse large B-cell lymphoma, distinct archetypes could guide personalized treatment decisions.

Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...

T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their ...

Jacob E. Berchuck, MD, discusses research on plasma epigenomic profiling in metastatic castration-resistant prostate cancer.

Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 ...

The Calibr-Skaggs Institute for Innovative Medicines, the drug development division of Scripps Research, today announced a ...

Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...

In India, two cancer patients treated with CAR T therapy have survived three years in one of the longest follow-ups in South ...

Catherine Sherry died in London in May, where she was undergoing specialised cancer treatment.